The present invention is directed to compounds of formula (I), 1 which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

 
Web www.patentalert.com

< Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists

< Estrogen receptor modulators

> Treating syndrome X with substituted tetralins and indanes

> Beta 2-adrenergic receptor agonists

~ 00210